ASRS
TRVI icon

Arizona State Retirement System’s Trevi Therapeutics TRVI Stock Holding History

Arizona State Retirement System’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Buy
26,434
+3,019
+13% +$43.9K ﹤0.01% 1547
2026
Q1 		$279K Sell
23,415
-648
-3% -$7.25K ﹤0.01% 1754
2025
Q4 		$301K Sell
24,063
-599
-2% -$6.92K ﹤0.01% 1749
2025
Q3 		$226K Buy
+24,662
New +$185K ﹤0.01% 1908

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Arizona State Retirement System's TRVI Position: Q2 2026 in Review

Arizona State Retirement System increased its Trevi Therapeutics (TRVI) stake by 13% in Q2 2026, buying an estimated $43.9K and bringing the position to 26,434 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Arizona State Retirement System first reported a position in TRVI in Q3 2025 and has held it in 4 quarters since. 217 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • Arizona State Retirement System held 26,434 shares of Trevi Therapeutics worth $493K as of Q2 2026.
  • Arizona State Retirement System bought 3,019 Trevi Therapeutics shares in Q2 2026, an estimated $43.9K.
  • Trevi Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1547 holding.
  • Arizona State Retirement System first reported a position in Trevi Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 217 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.